Company news
Jenkem Technology Co., Ltd. news in 2024
Jenkem Technology Co., Ltd.'s news releases, calls and decks from 2024, newest first.
Announcement on Change of Employee Representative Supervisor and Chairman of the Board of Supervisors
November 27, 2024
Announcement on the Vesting Results of the 2nd Vesting Period of the Part Reserved for Grant under the 2021 Restricted Stock Incentive Plan and Listing of Shares
November 13, 2024
Announcement on Voluntary Disclosure of the First Subject Being Enrolled in Phase II Clinical Trial of Pegylated Irinotecan in Treating Triple Negative Breast Cancer with Brain Metastasis
November 12, 2024
Announcement on Resolution of the 11th Meeting of the 3rd Board of Directors
November 8, 2024
Announcement on Correction of Report for Q3 2024
November 3, 2024
Announcement on Closing Some Investment Projects Financed by Raised Funds and Using Residual Raised Funds to Permanently Supplement Current Capital
October 30, 2024
Announcement on Voluntary Disclosure of the First Subject Being Enrolled in Phase III Clinical Trial of Polyethylene Glycol Irinotecan for Treatment of Small Cell Lung Cancer
September 29, 2024
Announcement Published in a Journal Regarding Voluntary Disclosure of Phase II Study on the Safety, Tolerability and Preliminary Efficacy of Polyethylene Glycol Irinotecan as Second-Line Monotherapy for Small Cell Lung Cancer
September 4, 2024
Announcement on Meeting the Vesting Conditions in the 2nd Vesting Period of Those Reserved for Grant in the 2021 Restricted Stock Incentive Plan
August 29, 2024